Answers are grounded in this paper and cite their sources.
Background and aims The hallmarks framework organizes aging into conserved cellular processes, but clinicians face patients with risk states, multimorbidity, and functional decline across fragmented specialty systems. This paper translates hallmarks-oriented aging biology into a clinically oriented translational framework, framing healthy aging as the outcome of clinical risk modulation across the full prevention continuum: primary, secondary, and tertiary. Methods A PRISMA-ScR-guided scoping review and conceptual synthesis was conducted. PubMed, Scopus, and Web of Science were searched from inception to 31 December 2025. Structured screening of 2400 records yielded 78 included sources. Data were synthesized narratively to map relationships between aging biology, clinical risk domains, and functional outcomes; no quantitative pooling was undertaken. Results We propose a dual-axis interpretation of aging trajectories—inflammaging (content/biomarker-accessible risk) and fibrosiging (form/function-expressed vulnerability)—mapped to five clinical risk domains (cardiovascular, metabolic, cognitive, skeletal, functional) connected by six mechanisms of system transition. Evidence mapping suggests that pharmacological prevention, early diagnosis, and rehabilitation may jointly contribute to preserving function, independence, and resilience (health span). Included sources consistently supported domain-specific risk reduction but did not provide integrated cross-domain estimates; the combined system effect remains under-quantified. Conclusions The dual-axis framework is proposed as a potential translational bridge between geroscience and clinical medicine. The mapped evidence base supports pragmatic trials and pharmacoepidemiologic research designed to estimate cross-domain healthspan effects. Integrated risk modulation is presented as a hypothesis-generating framework requiring empirical validation rather than as a validated clinical model.
No takes yet. Share an insight, caveat, or question.
Alejandro Carballo (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: